NextCell Pharma
QVance AB Publishes Article on Particulates in Cell and Gene Therapy Products in Collaboration with ISCT
QVance, founded by cell therapy developers to support other cell therapy developers, aims to become the leading quality analysis company for CGT in the Nordic region. With NextCell's expertise as a foundation, QVance provides quality control tailored to the industry's specific demands, supporting the development of safe therapies.
Dr. Davies comments:
"It is essential that we, together with regulators and industry, establish unified guidelines for CGT. QVance builds on our solid experience in cell therapy to provide other developers with high-quality, practical solutions."
* NextCell Pharma AB, "NextCell" or the "Company", Nasdaq First North Growth Market: NXTCL
| Datum | 2024-11-08, kl 13:00 |
| Källa | Cision |
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.